🇺🇸 betaloc in United States

940 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dizziness — 126 reports (13.4%)
  2. Asthenia — 122 reports (12.98%)
  3. Dyspnoea — 118 reports (12.55%)
  4. Nausea — 102 reports (10.85%)
  5. Diarrhoea — 87 reports (9.26%)
  6. Blood Pressure Increased — 81 reports (8.62%)
  7. Myocardial Infarction — 80 reports (8.51%)
  8. Headache — 76 reports (8.09%)
  9. Atrial Fibrillation — 74 reports (7.87%)
  10. Pyrexia — 74 reports (7.87%)

Source database →

betaloc in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is betaloc approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for betaloc in United States?

Shengjing Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.